12:00 AM
 | 
Oct 14, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Auxilium, Vivus, Mitsubishi Tanabe Pharma sales and marketing update

Vivus granted Auxilium exclusive rights to commercialize erectile dysfunction (ED) drug Stendra avanafil in the U.S. and Canada. Vivus will receive a $30 million license fee and is eligible for up to $270...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >